The best correlation of the new index of hyperandrogenism with the grade of increased body hair

被引:19
作者
Cibula, D
Hill, M
Starka, L
机构
[1] Dept Obstet & Gynecol, Prague 12000 2, Czech Republic
[2] Inst Endocrinol, Prague 11000, Czech Republic
关键词
D O I
10.1530/eje.0.1430405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Hyperandrogenemia is the most frequent endocrine disorder in fertile women causing a variety of negative metabolic disturbances. Establishing the diagnosis of androgen overproduction has important implications for the follow-up and treatment of patients. The aim of our study was to identify the optimal laboratory marker of androgen production by correlating the markers to the presence or grade of increased body hair as a clinical sign of hyperandrogenism. Design: Prospective observational study. Methods: A total of 62 women with acne were included into the study. The serum concentrations of testosterone, androstenedione, dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS) and sex hormone-binding globulin (SHBG) were evaluated. The index of free testosterone (IFT) and a new index of hyperandrogenism (IHA) were calculated. The monitored laboratory markers were correlated to the presence or grade of increased body hair using several statistical methods. Results: The statistical significance of differences between the average levels of laboratory markers between hirsute and non-hirsute women decreased in the following order: IHA, androstenedione and DHEA. Of all the above laboratory markers, only increased IHA was present significantly more often in hirsute women. The significance of correlation between the grade of increased body hair and the tested variables decreased in the following order: IHA, IFT, DHEA, androstenedione, DHEAS and testosterone. Conclusions: The clinical marker of hyperandrogenism correlates most closely to IHA, reflecting the levels of all commonly determined androgens or androgen precursors and SHBG, Its simple calculation makes IHA a suitable tool for determining total production of androgens in clinical practice, especially in cases with borderline elevations of values.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 16 条
[1]   The plasminogen activator system in women with polycystic ovary syndrome [J].
Atiomo, WU ;
Bates, SA ;
Condon, JE ;
Shaw, S ;
West, JH ;
Prentice, AG .
FERTILITY AND STERILITY, 1998, 69 (02) :236-241
[2]   Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome [J].
Cibula, D ;
Cífková, R ;
Fanta, M ;
Poledne, R ;
Zivny, J ;
Skibová, J .
HUMAN REPRODUCTION, 2000, 15 (04) :785-789
[3]   CLINICAL IMPLICATIONS OF HYPERINSULINEMIA IN WOMEN [J].
CONWAY, GS ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1993, 39 (06) :623-632
[4]  
DAHLGREN E, 1994, FERTIL STERIL, V61, P455
[5]  
DAHLGREN E, 1992, FERTIL STERIL, V57, P505
[6]   beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome [J].
Dunaif, A ;
Finegood, DT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :942-947
[7]   INSULIN SECRETORY DEFECTS IN POLYCYSTIC-OVARY-SYNDROME - RELATIONSHIP TO INSULIN SENSITIVITY AND FAMILY HISTORY OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
EHRMANN, DA ;
STURIS, J ;
BYRNE, MM ;
KARRISON, T ;
ROSENFIELD, RL ;
POLONSKY, KS .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :520-527
[8]   CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN [J].
FERRIMAN, D ;
GALLWEY, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1961, 21 (11) :1440-+
[9]  
Franks S, 1999, ANN ENDOCRINOL-PARIS, V60, P131
[10]   Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families [J].
Govind, A ;
Obhrai, MS ;
Clayton, RN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :38-43